• MDB Direct
  • Community Portal
  • Submit Your Big Idea
MDB Capital
  • Why Public Venture?
    • What is Public Venture?
    • Public Venture Advantage
    • How to Invest
    • MDB Outcomes
  • Why MDB?
    • MDB Difference
    • Investment Criteria
    • Curation Process
    • Outcomes
    • Launch Capabilities
    • MDB Capital Brokerage
    • Community
      • Membership Group
      • Member Criteria & Benefits
  • MDB Direct
    • Overview
    • MDB Direct
    • IRAs
    • Open an Account
  • Media
    • Videos
    • Press Releases
    • Articles
    • Reports
  • About
    • Overview
    • Our Platform
    • Value Creation
    • Join Us
    • Contact
    • Leadership Team
    • Submit Big Idea
    • Subsidiaries
  • MDBH Investors
    • Overview
    • Press Releases
    • SEC Filings
    • Stock Info
    • Governance
    • Email Alerts
    • IR Contact
    • Events
Select Page
National Renewable Energy Lab (NREL) working with Invizyne

National Renewable Energy Lab (NREL) working with Invizyne

by Tony Dammicci | Jul 26, 2024

2024: BioTech’s Year To Shine

2024: BioTech’s Year To Shine

by Staff | Jan 3, 2024

Cue Biopharma: Leading New Revolution In Cancer Treatments

Cue Biopharma: Leading New Revolution In Cancer Treatments

by Staff | Dec 4, 2023

Recessions, The Fed and Where to Find Opportunities in a New Bull Market

Recessions, The Fed and Where to Find Opportunities in a New Bull Market

by Staff | Aug 1, 2023

The Urgency Behind Biotech M&A

The Urgency Behind Biotech M&A

by Staff | May 9, 2023

« Older Entries

Recent Posts

  • ClearSign Technologies Announces Order for Multi Heater Project for Texas Petrochemical Facility
  • MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies
  • MDB Capital Collaborates with Mayo Clinic to Advance Anti-Senescence Platform
  • New PatentVest Pulse Report Delves into Transformative Innovations in MASH Diagnostics
  • New PatentVest Pulse Report Reveals Transformative Trends in Portable ECG Monitoring

Recent Comments

    Archives

    • July 2024
    • May 2024
    • April 2024
    • February 2024
    • January 2024
    • November 2023
    • October 2023
    • June 2023
    • May 2023
    • November 2022
    • October 2022
    • August 2022
    • July 2022
    • June 2022

    Categories

    • Press Releases

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Stay Informed

    Terms of Use  |  Governance  |  Business Continuity  |  Member FINRA/SIPC  |  FINRA’s BrokerCheck  |  Disclosures
    © 2024 MDB Capital